Relay Therapeutics (RLAY) Stock Highlights

4.66 | -2.92%

2024-11-21 03:48:57

Relay Therapeutics Inc is a clinical-stage, precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company is advancing its pipeline of medicines to address targets in precision oncology, including its lead product candidates, RLY-4008 and RLY-1971, as well as its PI3Ka mutant selective program, known as the RLY-PI3K1047 program. Its initiated a Phase 1 clinical trial for RLY-1971 in patients with advanced solid tumors in the first quarter of 2020 and a first-in-human clinical trial of RLY-4008 enriched for patients with advanced solid tumors having oncogenic FGFR2 alterations in the third quarter of 2020.

Statistics

Range Today

4.5 4.8

Volume Today 2.92M

Range 1 Year

4.7 12.14

Volume 1 Year 352.98M

Range 3 Year

4.7 35.76

Volume 3 Year 908.15M

Range 10 Year

4.7 64.37

Volume 10 Year 1.11B

Highlights

Market Capitalization 1.04B (small)

Floating Shares 126.59M

Current Price 4.66

Price To Earnings -2.33

Price To Revenue 24.48

Price To Book 1.23

Earnings Per Share -2.64

Payout Ratio 0%

Performance

Latest -2.92%

1 Month -30.24%

3 Months -35.37%

6 Months -29.82%

1 Year -45.43%

3 Years -86.44%

5 Years -86.63%

10 Years -86.63%

Benchmarks

Market Capitalization

108 / 368

Gross Profits

124 / 278

Total Revenue

147 / 300

Total Rank

248 / 368

Free Cashflow

316 / 352

Performance 5 years

253 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.